Treatment of Pleural Empyema in Hospital-Acquired (Healthcare-Acquired) Pleural Infection

Managing pleural empyema in the hospital-acquired setting requires a distinct approach — the microbial profile and clinical context differ substantially from community-acquired infection, and both antibiotic strategy and procedural management must reflect this.

Clinical scenario

Hospital-acquired (healthcare-acquired) pleural infection

In the hospital-acquired setting, pleural infection usually arises secondary to nosocomial pneumonia, trauma, and surgery. The implicated organisms span Gram-positive and Gram-negative aerobes as well as anaerobic bacteria, making broad-spectrum empirical cover essential.

Treatment approach

The protocol combines empirical broad-spectrum antibiotic therapy — covering the full range of likely pathogens encountered in nosocomial pleural infection, including organisms of particular concern in the healthcare setting — with prompt procedural intervention. The antibiotic strategy involves an intravenous phase followed by step-down to oral therapy on clinical improvement; the complete regimen, agent selection, and duration are specified in the full protocol.

Treatment goals

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1183/20734735.0146-2023

View source ↗